Radioembolization plus Immune Checkpoint Inhibitor Therapy Compared with Radioembolization plus Tyrosine Kinase Inhibitor Therapy for the Treatment of Hepatocellular Carcinoma
Kirema Garcia-Reyes, Ricki A Gottlieb, K. Menon, V. Bishay, Rahul Patel, Rajesh Patel, Scott Nowakowski, Max W. Sung, Thomas U. Marron, William Gansa, Jack Zhang, Sahitya C. Raja, Daniel Shilo, A. Fischman, Robert Lookstein, Edward Kim
Topics & Concepts
MedicineResponse Evaluation Criteria in Solid TumorsCommon Terminology Criteria for Adverse EventsInternal medicineHepatocellular carcinomaAdverse effectOncologyGastroenterologyProgression-free survivalPropensity score matchingCombination therapyProgressive diseaseOverall survivalChemotherapyHepatocellular Carcinoma Treatment and PrognosisCholangiocarcinoma and Gallbladder Cancer StudiesCancer Research and Treatment